MRP1-Collateral Sensitizers as a Novel Therapeutic Approach in Resistant Cancer Therapy: An In Vitro and In Vivo Study in Lung Resistant Tumor

Multidrug resistance (MDR) is the main obstacle to current chemotherapy and it is mainly due to the overexpression of some efflux transporters such as MRP1. One of the most studied strategies to overcome MDR has been the inhibition of MDR pumps through small molecules, but its translation into the c...

Ful tanımlama

Detaylı Bibliyografya
Asıl Yazarlar: Riganti, Chiara, Giampietro, Roberta, Kopecka, Joanna, Costamagna, Costanzo, Abatematteo, Francesca Serena, Contino, Marialessandra, Abate, Carmen
Materyal Türü: Online Makale Metin
Dil:English
Baskı/Yayın Bilgisi: MDPI 2020
Konular:
Article
Online Erişim:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7247425/
https://www.ncbi.nlm.nih.gov/pubmed/32397184
http://dx.doi.org/10.3390/ijms21093333

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7247425/
https://www.ncbi.nlm.nih.gov/pubmed/32397184
http://dx.doi.org/10.3390/ijms21093333

Benzer Materyaller